EDGAR Filing Documents for 0001199835-13-000549

Form 20FR12B/A - Registration of securities [Section 12(b)]: [Amend]

SEC Accession No. 0001199835-13-000549

Filing Date

2013-08-30

Accepted

2013-08-29 19:44:29

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	PACIFIC THERAPEUTICS LTD. 20-FA 2ND AMENDED	pt_20fa2nd-15680.htm	20FR12B/A	1044313
2	2012 STOCK OPTION PLAN	exhibit_2-5.htm	EX-2.5	77365
3	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARB	exhibit_12-1.htm	EX-12.1	17562
4	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARB	exhibit_12-2.htm	EX-12.2	18090
5	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARB	exhibit_13-1.htm	EX-13.1	8079
6	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARB	exhibit_13-2.htm	EX-13.2	8072
7	INDEPENDENT AUDITOR?S REPORT	exhibit_15-1.htm	EX-15.1	10538
8	ANNUAL FINANCIAL STATEMENTS AS OF DECEMBER 31, 2012 AND 2011 , AS AMENDED	exhibit_15-3.htm	EX-15.3	832637
9	(UNAUDITED) QUARTERLY FINANCIAL STATEMENTS AS OF MARCH 31, 2013, AS AMENDED	exhibit_15-5.htm	EX-15.5	616506
11		leed_header.jpg	GRAPHIC	36449
12		pt-figure1.gif	GRAPHIC	46647
	Complete submission text file	0001199835-13-000549.txt		2748866

Mailing Address 1500 - 409 GRANVILLE STREET VANCOUVER A1 V6T2C3

Business Address 1500 - 409 GRANVILLE STREET VANCOUVER A1 V6T2C3 (604)738-1049

Pacific Therapeutics Ltd. (Filer) CIK: 0001579026 (see all company filings)